医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

SNOWPLUS, the Maker of China’s E-cigarette Standard

2019年10月09日 PM08:26
このエントリーをはてなブックマークに追加


 

BEIJING

China had just celebrated its 70th Founding Anniversary, and is vigorously developing its diversified economy, one of which is e-cigarettes, a special industry being taken more and more seriously.

As an emerging alternative to traditional tobacco, the new tobacco products created a global sales amounted to USD $24.7 billion in 2018, and the figure is expected to be up to USD $45 billion in 2024. More than 95% of all the world’s e-cigarettes are made in China, and over 90% are exported from here.

In China where e-cigarettes were invented, nearly 700 independent e-cig brands are working on winning over the 300 million Chinese smokers in many ways. “Quality is above all other marketing techniques,” said Sa Wang, a senior manager of SNOWPLUS – the leading producer in China’s e-cig industry. Every single SNOWPLUS product will be given an ultimate toxicity test to verify its safety by authoritative inspection agencies before it is put onto the market – this is second to none in China.

Besides, SNOWPLUS is vigorously pushing on the standardization of e-cigarette industry in China. On August 29, 2019, China’s first e-cigarette bluebook was presented by Tsinghua University’s Public Health and Technical Supervision Research Group with the title of Public Health and Technical Supervision Studies: Report on the Supervision of the E-Cigarette Industry. The ownership of the report was finally granted to SNOWPLUS by the research group of Tsinghua University.

“We appreciate SNOWPLUS’s contributions, as its ultimate goal is to set up the industrial standards and to make China’s e-cigarettes go much further and more stably,” said Yao Jide, the executive vice president of the Electronic Cigarette Industry Committee. SNOWPLUS is expected to be the vice-chairman unit of this committee at the end of this year.

The e-cigarette incident in the USA once insinuated doubts of the public about the new product. On September 28, however, the Centers for Disease Control and Prevention (CDC) revealed the truth on its official website that, “the latest findings from the investigation into lung injuries caused by vaping, suggest that THC products played a role in the outbreak. Most of the people (77%) were found using THC-containing products, or both THC-containing products and nicotine-containing products.

“That is exactly the reason why we should strive to push forward the introduction of industrial and national standards,” said Sa Wang. “Our ultimate goal is to improve the health of 1 billion smoking population worldwide.”

View source version on businesswire.com: https://www.businesswire.com/news/home/20191009005352/en/

CONTACT

SNOWPLUS

Shen Zhou

info@snowplus.cn

086-4000176690

https://www.snowplus.cn/

 

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 印尼生命科学与技术学院在NCRM NICHE 2021上赢得第16届Fujio Cup Quiz大赛;印度Rajalakshmi工程学院获得亚军
  • 辉凌将在ACG 2021上展示基于微生物群的在研活体生物治疗药物RBX2660用于治疗艰难梭菌反复感染和IBD患者的获奖真实临床转归分析
  • ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
  • 硕迪B轮成功融资1亿美元,利用先进的计算和结构药物设计平台加速开发改变患者命运的药物
  • CANbridge Pharmaceuticals CAN103 Investigational New Drug Application Approved in China for Treatment of Gaucher Disease